Daratumumab Injection. [Photo provided to chinadaily.com.cn]
In the drug field, Daratumumab is among the major five products introduced in the Chinese market during the CIIE. The injection is the only drug presently approved by China for treating primary light chain amyloidosis, a rare disease.
